| Spatial transcriptomics at subspot resolution with BayesSpace E Zhao, MR Stone, X Ren, J Guenthoer, KS Smythe, T Pulliam, ... Nature biotechnology 39 (11), 1375-1384, 2021 | 456 | 2021 |
| Merkel cell carcinoma in the age of immunotherapy: Facts and hopes A Colunga, T Pulliam, P Nghiem Clinical Cancer Research, clincanres. 0439.2017, 2017 | 98 | 2017 |
| Glycolysis, glutaminolysis and fatty acid synthesis are required for distinct stages of KSHV lytic replication EL Sanchez, TH Pulliam, TA Dimaio, AB Thalhofer, T Delgado, ... Journal of virology, JVI. 02237-16, 2017 | 86* | 2017 |
| Polyomavirus‐driven Merkel cell carcinoma: Prospects for therapeutic vaccine development S Tabachnick‐Cherny, T Pulliam, C Church, DM Koelle, P Nghiem Molecular carcinogenesis 59 (7), 807-821, 2020 | 46 | 2020 |
| Polybrominated diphenyl ethers: structure determination and trends in antibacterial activity H Liu, K Lohith, M Rosario, TH Pulliam, RD O’Connor, LJ Bell, CA Bewley Journal of natural products 79 (7), 1872-1876, 2016 | 36 | 2016 |
| Narrow excision margins are appropriate for Merkel cell carcinoma when combined with adjuvant radiation: Analysis of 188 cases of localized disease and proposed management … ES Tarabadkar, T Fu, K Lachance, DS Hippe, T Pulliam, H Thomas, JY Li, ... Journal of the American Academy of Dermatology 84 (2), 340-347, 2021 | 33 | 2021 |
| BayesSpace enables the robust characterization of spatial gene expression architecture in tissue sections at increased resolution E Zhao, MR Stone, X Ren, T Pulliam, P Nghiem, JH Bielas, R Gottardo bioRxiv, 2020.09. 04.283812, 2020 | 20 | 2020 |
| Mixing and delivery of multiple controlled oxygen environments to a single multiwell culture plate M Yao, T Sattler, ZN Rabbani, T Pulliam, G Walker, MP Gamcsik American Journal of Physiology-Cell Physiology 315 (5), C766-C775, 2018 | 18 | 2018 |
| Intersection of two checkpoints: could inhibiting the DNA damage response checkpoint rescue immune checkpoint-refractory cancer? PH Goff, R Bhakuni, T Pulliam, JH Lee, ET Hall, P Nghiem Cancers 13 (14), 3415, 2021 | 16 | 2021 |
| Transcriptional and functional analyses of neoantigen-specific CD4 T cells during a profound response to anti-PD-L1 in metastatic Merkel cell carcinoma C Church, T Pulliam, N Longino, SY Park, KS Smythe, V Makarov, N Riaz, ... Journal for immunotherapy of cancer 10 (9), 2022 | 12 | 2022 |
| Merkel cell polyomavirus-specific and CD39+ CLA+ CD8 T cells as blood-based predictive biomarkers for PD-1 blockade in Merkel cell carcinoma H Ryu, TM Bi, TH Pulliam, K Sarkar, CD Church, N Kumar, ... Cell Reports Medicine 5 (2), 2024 | 6 | 2024 |
| Circulating cancer-specific CD8 T cell frequency is associated with response to PD-1 blockade in Merkel cell carcinoma T Pulliam, S Jani, L Jing, H Ryu, A Jojic, C Shasha, J Zhang, ... Cell Reports Medicine 5 (2), 2024 | 6 | 2024 |
| Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8+ T cells in persons with previous COVID-19 ES Ford, K Mayer-Blackwell, L Jing, KJ Laing, AM Sholukh, R St. Germain, ... Nature Immunology 25 (1), 166-177, 2024 | 6 | 2024 |
| Characterization of immunosuppressive myeloid cells in Merkel cell carcinoma: correlation with resistance to PD-1 pathway blockade S Tabachnick-Cherny, T Pulliam, HJ Rodriguez, X Fan, DS Hippe, ... Clinical Cancer Research 30 (6), 1189-1199, 2024 | 5 | 2024 |
| Extended duration of treatment using reduced-frequency dosing of anti-PD-1 therapy in patients with advanced melanoma and Merkel cell carcinoma LML Tachiki, DS Hippe, K Williams Silva, ET Hall, W McCamy, D Fritzsche, ... Cancer Immunology, Immunotherapy 72 (11), 3839-3850, 2023 | 5 | 2023 |
| CD8+ T cell clonotypes from prior SARS-CoV-2 infection predominate during the cellular immune response to mRNA vaccination ES Ford, K Mayer-Blackwell, L Jing, AM Sholukh, RS Germain, ... Research Square, 2022 | 4 | 2022 |
| 50 Merkel cell polyomavirus-specific CD8 T cells in blood, but not in tumors, correlate with immunotherapy response in merkel cell carcinoma T Pulliam, S Jani, L Jing, J Zhang, R Kulikauskas, C Church, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 3 | 2022 |
| 1045 High dimensional profiling of merkel cell polyomavirus-specific T cells in response to anti-PD-1 immunotherapy H Ryu, T Bi, K Sarkar, C Church, N Ramchurren, T Pulliam, S Fling, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 3 | 2022 |
| An intratumoral STING agonist-mediated clinical response in PD-L1-refractory MCC via an unexpected mechanism of action TH Pulliam, R Bhakuni, S Jani, K Smythe, B Seaton, L Tachiki, ... Journal of Investigative Dermatology 142 (10), 2839, 2022 | 2 | 2022 |
| Impact of duration of immunotherapy on clinical outcomes in advanced Merkel cell carcinoma patients responding to first-line immunotherapy LM Tachiki, L Zawacki, DS Hippe, Y Moshiri, N Alexander, T Akaike, ... Journal of Investigative Dermatology 142 (10), 2840, 2022 | 1 | 2022 |
